Establishing an Organotypic System for Investigating Multimodal Neural Repair Effects of Human Mesenchymal Stromal Stem Cells

Current Protocols in Stem Cell Biology
Devang K ThakorYang D Teng

Abstract

Human mesenchymal stromal stem cells (hMSCs) hold regenerative medicine potential due to their availability, in vitro expansion readiness, and autologous feasibility. For neural repair, hMSCs show translational value in research on stroke, spinal cord injury (SCI), and traumatic brain injury. It is pivotal to establish multimodal in vitro systems to investigate molecular mechanisms underlying neural actions of hMSCs. Here, we describe a platform protocol on how to set up organotypic co-cultures of hMSCs (alone or polymer-scaffolded) with explanted adult rat dorsal root ganglia (DRGs) to determine neural injury and recovery events for designing implants to counteract neurotrauma sequelae. We emphasize in vitro hMSC propagation, polymer scaffolding, hMSC stemness maintenance, hMSC-DRG interaction profiling, and analytical formulas of neuroinflammation, trophic factor expression, DRG neurite outgrowth and tropic tracking, and in vivo verification of tailored implants in rodent models of SCI. © 2018 by John Wiley & Sons, Inc.

References

Feb 1, 1995·Journal of Neurotrauma·D M BassoJ C Bresnahan
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Feb 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·Yang D TengEvan Y Snyder
Oct 1, 1959·The Journal of Experimental Zoology·R G HARRISON
Feb 26, 2004·Proceedings of the National Academy of Sciences of the United States of America·Yang D TengRobert M Friedlander
Nov 9, 2005·Proceedings of the National Academy of Sciences of the United States of America·Simona NeumannAllan I Basbaum
Feb 3, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Pascal G LeclereDavid Tonge
Jul 12, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Devang ThakorIchiro Nishimura
Oct 30, 2007·Nature Neuroscience·Joachim Scholz, Clifford J Woolf
Sep 17, 2008·Proceedings of the National Academy of Sciences of the United States of America·Hirokazu OhtakiDarwin J Prockop
Jan 21, 2009·Biomaterials·Devang K ThakorYasuhiko Tabata
Apr 30, 2009·Annual Review of Neuroscience·Michael CostiganClifford J Woolf
Nov 27, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Masanori SasakiJeffery D Kocsis
Dec 21, 2012·Science Translational Medicine·Yang D TengEvan Y Snyder
Mar 29, 2014·Restorative Neurology and Neuroscience·Yoshihisa SuzukiChizuka Ide
Feb 27, 2015·Cell Transplantation·Hariprakash HaragopalYang D Teng
Jul 27, 2015·Experimental Neurology·Alexander E RopperYang D Teng
Feb 13, 2016·BMC Research Notes·James N SleighGiampietro Schiavo
Jan 18, 2017·Proceedings of the National Academy of Sciences of the United States of America·Alexander E RopperYang D Teng
Apr 27, 2017·Expert Opinion on Biological Therapy·Svitlana Garbuzova-DavisPaul R Sanberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.